feed,title,long_url,short_url
Investing,U.S. FDA grants priority review to Roche's bispecific antibody Glofitamab,https://www.investing.com/news/stock-market-news/us-fda-grants-priority-review-to-roches-bispecific-antibody-glofitamab-2974342,https://da.gd/bl8wL
